Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice

Epilepsy and Behavior

Volumn 11, Issue 1, 2007, Pages 1-5

  Yilmaz, Ismail ^a   Sezer, Zafer ^b   Kayir, Hakan ^a   Uzbay, Tayfun I ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Antidepressants; Maximal electroconvulsive shock; Mice; Mirtazapine; Pentylenetetrazole; Seizure

Indexed keywords

MIRTAZAPINE; PENTETRAZOLE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE COMPARISON; ELECTRIC SHOCK; GRAND MAL SEIZURE; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; MYOCLONUS SEIZURE; NONHUMAN; RIGHTING REFLEX; SEIZURE; TONIC SEIZURE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHI-SQUARE DISTRIBUTION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; ELECTROSHOCK; EPILEPSIES, MYOCLONIC; MALE; MIANSERIN; MICE; PENTYLENETETRAZOLE; RANDOM ALLOCATION; SEIZURES;

EID: 34447639770     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.04.004     Document Type: Article

References (31)

1. Kanner A., and Nieto J.C.R. Depressive disorders in epilepsy. Neurology 53 Suppl. 2 (1999) 26-32
2. Kühn K.U., Quednow B.B., Thiel M., et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4 (2003) 674-679
3. Pisani F., Spina E., and Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 40 Suppl. 10 (1999) S48-S56
4. Montgomery S.A. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract 59 (2005) 1435-1440
5. O'Connor W.T., and Leonard B.E. Effect on chronic administration of the 6-aza analogue of mianserin (org 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomised rats in the "open-field" apparatus. Neuropharmacology 25 (1986) 267-270
6. Holm K.J., and Markham A. Mirtazapine: a review of its use in major depression. Drugs 57 (1999) 607-631
7. Burrows G.D., and Kremer C.M. Mirtazapine: clinical advantages in the treatment of depression. J Clin Psychopharmacol 17 Suppl. 1 (1997) 34S-39S
8. Sterr A., Padberg F., Amann B., et al. Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline. J Clin Psychiatry 67 (2006) 325-326
9. Buckley N.A., and Faunce T.A. "Atypical" antidepressants in overdose, clinical considerations with respect to safety. Drug Saf 26 (2003) 539-551
10. Montgomery S.A. Safety of mirtazapine: a review. Int Clin Psychopharmacol 10 Suppl. 4 (1995) 37-45
11. Juckel G., Schüle C., Pogarell O., et al. Epileptiform EEG patterns induced by mirtazapine in both psychiatric patients and healthy volunteers. J Clin Psychopharmacol 23 (2003) 421-422
12. Münchau A., Langosch J.M., Gerschlager W., et al. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry 76 (2005) 527-533
13. Kaputlu I., and Uzbay T. l-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice. Brain Res 753 (1997) 98-101
14. Uzbay T.I., Kayir H., and Ceyhan M. Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors. Neuropsychopharmacology 32 (2007) 412-416
15. Su R.B., Wei X.L., Zheng J.Q., Liu Y., Lu X.Q., and Li J. Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav 77 (2004) 345-349
16. De Boer T., Ruigt G.S.F., and Berendsen H.H. The alpha-2-selective adrenoreceptor antagonist Org 3770 (mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission. Hum Psychopharmacol 10 (1995) S107-S118
17. 1A receptor activation. Brain Res Bull 63 (2004) 237-241
18. Kostowski W., Dyr W., and Krzascik P. The abilities of 5-HT3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol 10 (1993) 369-373
19. Grant K.A., Hellevuo K., and Tabakoff B. The 5-HT3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin Exp Res 18 (1994) 410-414
20. Genkova-Papazova M., Lazarova-Bakarova M., and Petkov V.D. The 5-HT2 receptor antagonist ketanserine prevents electroconvulsive shock- and clonidine-induced amnesia. Pharmacol Biochem Behav 49 (1994) 849-852
21. Wada Y., Shiraishi J., Nakamura M., and Koshino Y. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res 747 (1997) 338-442
22. Gariboldi M., Tutka P., Samanin R., and Vezzani A. Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats. Eur J Pharmacol 350 (1998) 181-188
23. 1A receptors increases the seizure threshold for picrotoxin in mice. Eur J Pharmacol 527 (2005) 105-110
24. Dunn R.W., and Corbett R. Yohimbine-induced seizures involve NMDA and GABAergic transmission. Neuropharmacology 31 (1992) 389-395
25. Dailey J.W., and Naritoku D.K. Antidepressants and seizure: clinical anecdotes overshadow neuroscience. Biochem Pharmacol 52 (1996) 1323-1329
26. Uzbay I.T., Saglam E., Kayir H., Celik T., and Beyazyurek M. Effects of fluoxetine on ethanol withdrawal syndrome in rats. J Psychiatr Res 38 (2004) 445-450
27. Saglam E., Uzbay I.T., Kayir H., Celik T., and Beyazyurek M. Effects of venlafaxine on ethanol withdrawal syndrome in rats. Fundam Clin Pharmacol 18 (2004) 693-698
28. Ceyhan M., Kayir H., and Uzbay I.T. Investigation of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. J Psychiatr Res 39 (2005) 191-196
29. Fisher R.S. Animal models of the epilepsies. Brain Res Brain Res Rev 14 (1989) 245-278
30. Schroeder H., Becker A., Grecksch G., Schroeder U., and Hoellt V. The effect of pentylenetetrazol kindling on synaptic mechanisms of interacting glutamatergic and opioid system in the hippocampus of rats. Brain Res 811 (1998) 40-46
31. Liao W.P., Chen L., Yi Y.H., et al. Study of antiepileptic effect of extracts from Acorus tatarinowii Schott. Epilepsia 46 Suppl. 1 (2005) 21-24